Cylanic_IRE_ForteHealthcare

Forte Healthcare Ltd is proud to announce the launch of Cylanic, a flavoured chewable tablet designed to provide effective treatment for bacterial infections in dogs and cats.

Cylanic combines amoxicillin (as trihydrate) and clavulanic acid, forming a potent antibiotic duo known for its broad-spectrum efficacy against various aerobic and anaerobic bacteria. This combination is effective for conditions such as skin diseases (including deep and superficial pyodermas), soft tissue infections, dental infections (e.g., gingivitis), urinary tract infections, respiratory diseases, and enteritis.

Available in three strengths – 50/12.5 mg, 250/62.5 mg, and 500/125 mg – Cylanic offers a flexible dosing regimen tailored to the weight and needs of both dogs and cats, ensuring precise and effective treatment. The tablets are highly concentrated, palatable with a vanilla flavour, hypoallergenic, and gluten-free, making administration easy and stress-free. Each strength is designed to cover 25% more body weight than standard amoxicillin and clavulanic acid tablets, ensuring efficient use and fewer tablets required per dose.

The innovative Easy Tab technology allows the tablets to be divided into 2 or 4 equal parts, ensuring accurate dosing. The packaging is designed for convenience, with perforated blisters that simplify dispensing and allow for precise quantity control without the need for scissors.

Cylanic is available now from all major veterinary wholesalers (in Ireland only).